Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06998628 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later May 30, 2026 → May 30, 2027
See other at-risk trials from Tanta University

Record History

  1. Primary completion pushed from May 30, 2026 to May 30, 2027 Completion pushed from Sep 30, 2026 to Sep 30, 2027 · Eligibility criteria expanded, about 9 words Show 2 more changesShow less
    • Completion pushed from Sep 30, 2026 to Sep 30, 2027
    • Eligibility criteria expanded, about 9 words
  2. Start date changed from estimate of Jul 2, 2025 to Jun 2, 2025v3
  3. Trial status: Not Yet Recruiting to Recruiting Start date: May 30, 2025 to Jul 2, 2025 · Site details revisedv2 Show 2 more changesShow less
    • Start date: May 30, 2025 to Jul 2, 2025
    • Site details revised
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Rheumatoid arthritis (RA) is a long-term inflammatory condition that leads to gradual damage of joints lined by synovial membranes, along with various potential effects outside of the joints. While RA can affect any joint, it typically involves the metacarpophalangeal, proximal interphalangeal, and metatarsophalangeal joints, as well as the wrists and knees. Symptoms related to the joints and surrounding tissues include swelling, tenderness upon touch, morning stiffness, and significant difficulty moving the affected joints
Trial Details
NCT Number NCT06998628
Lead Sponsor Tanta University
Collaborators: Dr. Mustafa Adel Mustafa Elmenawy Lecturer of Rheumatology and Rehabilitation, Faculty of Medicine - El-Azhar University - Damietta
Conditions Rheumatoid Arthritis
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov